AI In Action: Redefining Drug Discovery and Development
Clinical and Translational Science · 2025-02 · 18 (2)
DOI: 10.1111/cts.70149 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Science, online erschienen am 06.02.2025. Verfasst von Anshul Kanakia und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for AI, Data Science & AI, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIGMS NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for AI, Data Science & AI, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA.
- Certara, Radnor, Pennsylvania, USA.
- Department of Bioengineering and Therapeutics Sciences, School of Pharmacy and Medicine, University of California San Francisco, San Francisco, California, USA.
- Department of Chemistry, York College, City University of New York, New York, New York, USA.
ORCID-Profile: Mark Sale
Förderung
- NIGMS NIH HHS
Zitieren
APA
Kanakia, A., Sale, M., Zhao, L., & Zhou, Z. (2025). AI In Action: Redefining Drug Discovery and Development. Clinical and Translational Science, 18(2). https://doi.org/10.1111/cts.70149
Vancouver
Kanakia A, Sale M, Zhao L, Zhou Z. AI In Action: Redefining Drug Discovery and Development. Clinical and Translational Science. 2025;18(2). doi:10.1111/cts.70149
BibTeX
@article{Kanakia2025,
author = {Kanakia, Anshul and Sale, Mark and Zhao, Liang and Zhou, Zhu},
title = {AI In Action: Redefining Drug Discovery and Development},
journal = {Clinical and Translational Science},
year = {2025},
volume = {18},
number = {2},
doi = {10.1111/cts.70149}
}
EUVIMED